YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced unaudited consolidated financial results for the three months ended 1 November 2021.
Third-Quarter Reported Results
Key Figures | Q3 2021 | Growth(1) |
Total revenues | KRW 465.7 billion | 11.0% |
Operating Income | KRW 71.5 billion | 40.9% |
Net Income | KRW 58.1 billion | -8.4% |
(1) Results and percentages compare to equivalent 2020 period |
Financial Highlights
About GC Pharma
GC Pharma (formerly known as Green Cross Corporation) is a biopharmaceutical company that delivers life-saving and life-sustaining protein therapeutics and vaccines. Headquartered in Yongin, South Korea, GC Pharma is one of the leading plasma protein and vaccine product manufacturers globally and has been dedicated to quality healthcare solutions for more than half a century. Green Cross Corporation updated its corporate brand to GC Pharma in early 2018. Green Cross Corporation remains the company’s legal name.
This press release may contain forward-looking statements, which express the current beliefs and expectations of GC Pharma’s management. Such statements do not represent any guarantee by GC Pharma or its management of future performance and involve known and unknown risks, uncertainties and other factors. GC Pharma undertakes no obligation to update or revise any forward-looking statement contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule.
Contacts
Investor/Media Contact
HyunGoo Kang
gookang@gccorp.com
Yelin Jun
yelin@gccorp.com
Sohee Kim
shkim20@gccorp.com
Hansaem Kim
hs.kim@gccorp.com
HONG KONG--(BUSINESS WIRE)--Inocras Hong Kong, in partnership with Cancerinformation.com.hk Charity Foundation (CICF) and generously sponsored…
TOKYO--(BUSINESS WIRE)--The ASEAN-Japan Centre (AJC) renewed its official website (https://www.asean.or.jp/). On the top page of…
Being accredited allows Fortanix to establish strong credentials as a trusted data security provider with…
Exceeds Guidance Ranges with Record Revenue and Net Income Per Share BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN),…
DUBLIN--(BUSINESS WIRE)--The "South Korea Data Center Market - Investment Analysis & Growth Opportunities 2024-2029" report…
GUANGZHOU, China--(BUSINESS WIRE)--On May 3rd and 4th, the Guangzhou Opera House welcomed nearly 200 international…